Taizhou HoudeAoke Biomedical

• A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms

  Phase 1, Status unknown, 94 people, Feb 16, 2021

• Study of LP002 in Combination With Chemotherapy for Patients With Extensive Stage Small Cell Lung Cancer

  Phase 2, Status unknown, 46 people, Feb 5, 2021

Sources: clinicaltrials.gov